Medscape Medical NewsAll articles

Achieva, Ingenia, Ingenia CX, Ingenia Elition and Ingenia Ambition MR Systems

Philips Medical Systems Nederland B.V. • Radiology • 05/16/2022

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Philips' Achieva, Ingenia, and related MR systems are advanced diagnostic imaging tools that utilize magnetic resonance principles to generate detailed anatomical and physiological images for clinical diagnosis and procedural guidance. The key innovation in this R11.0 version is the SmartSpeed AI feature, which employs machine learning combined with Compressed-SENSE to significantly accelerate scan times while preserving or enhancing image quality, supported by hardware upgrades like a new GPU for improved reconstruction.

Summary

The Philips Achieva, Ingenia, Ingenia CX, Ingenia Elition, and Ingenia Ambition MR Systems are 1.5T and 3.0T magnetic resonance diagnostic devices designed for trained physicians to obtain cross-sectional images, spectroscopic images, and spectra of the head, body, or extremities. These systems operate on the principle of detecting relaxation signals from atomic nuclei within a strong magnetic field when excited by radio signals, subsequently reconstructing these signals into images. They support diagnostic imaging, therapy planning, and guidance for interventional procedures, with users able to customize scan parameters and synchronize acquisitions with physiological cycles. The core technological components such as magnets, coils, and amplifiers remain consistent with previous iterations, while these systems also support various previously cleared pulse sequences and coils. This R11.0 iteration introduces significant software and hardware enhancements, most notably the SmartSpeed AI feature, which integrates machine learning with the previously cleared Compressed-SENSE technology. SmartSpeed AI aims to achieve higher image acquisition accelerations while maintaining or improving image quality, alongside other software updates like SmartSpeed MotionFree, SmartSpeed 3D FreeBreathing, and MR Workspace. Non-clinical performance testing, including pixel-wise comparisons with ground truth data and a reader evaluation study by US board-certified radiologists, demonstrated that SmartSpeed AI provides comparable or better image quality, especially at high acceleration factors and low SNR levels, often with reduced scan times. Hardware upgrades include a new graphical processing unit in the host reconstruction computer for enhanced image reconstruction capabilities and an additional monitor for the operating console.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Magnetic Resonance ImagingSmartSpeed AIImage ReconstructionCompressed-SENSEMachine Learning1.5T MRI3.0T MRIPulse SequencesDiagnostic ImagingInterventional MRI

Device Metadata

Submission Number
K213583
Company
Philips Medical Systems Nederland B.V.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How does the SmartSpeed AI algorithm specifically balance image quality preservation with increased acceleration factors across different anatomical regions and patient populations?; What are the quantitative metrics used to define 'equal or better image quality' for SmartSpeed AI compared to traditional methods, particularly in low SNR scenarios?; Are there specific pulse sequences or imaging parameters where SmartSpeed AI offers the most significant improvement in scan time reduction or image quality enhancement?; How does the integration of the new graphical processing unit impact the reconstruction time for complex imaging sequences, especially those utilizing SmartSpeed AI?; What is the learning curve and training requirement for radiologists to effectively interpret images acquired with SmartSpeed AI, considering potential subtle differences in image texture or artifact profiles?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score25/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm, ground truth)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials(hardware)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, HBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Achieva, Ingenia, Ingenia CX, Ingenia Elition and Ingenia Ambition MR Systems - Philips Medical Systems Nederland B.V. | ESL FDA AI Device Intelligence